SJURVM schreef op 23 februari 2017 14:30:
$8.8 million total acquisition cost, including
$5.1 million in MDxHealth stock,
$280,000 in cash,
and up to an additional $3.3 million in cash in future milestones ( in 6 instalments)
In addition, MDxHealth will grant NovioGendix a bridge loan of $680,000 (or €0.6 million1) to repay outstanding debts of NovioGendix.
I think there is a 1.9$ m goodwill on the books.
Consolidation costs to be amortized over 10 years i seem to recall.